Launched in March 2017 and finalized in February 2023, BigData@Heart was a six-year project of the Innovative Medicines Initiative (IMI), an EU public-private consortium consisting of patient networks, learned societies, SMEs, pharmaceutical companies, and academia. BigData@Heart’s ultimate goal was to develop a Big Data-driven translational research platform of unparalleled scale and phenotypic resolution to deliver clinically relevant disease phenotypes, scalable insights from real-world evidence and insights driving drug development and personalised medicine through advanced analytics.
To learn more about the project’s achievements, visit the BigData@Heart website.
In this first podcast, Birgit Beger, CEO of the European Heart Network, discusses the hot topic of digital health technologies with Donna Fitzsimons, Head of the School of Nursing & Midwifery at Queen’s University Belfast, and Thomas Beer, voluntary representative of the German Heart Foundation. They look at digital technologies’ value for cardiovascular patients and healthcare professionals, and their wishes for their future development and use.
Listen to the podcast (30-minutes)
This second BigData@Heart podcast looks at the importance of gender differences in CVD
Dr Megan Molnar, epidemiologist of Bayer, discusses with experts Prof Hester den Ruijter, Peggy Maguire and Dr Maureen Cronin, the importance of sex differences in the predisposition, pathophysiology, epidemiology, therapeutic response and prognosis of cardiovascular disease.
Research gaps and the need for gender based therapeutic approaches are highlighted.
Click here to listen to the podcast.
BigData@Heart newsletters feature project updates, related events and policy updates.